Wordt geladen...
Clinical utility of eslicarbazepine: current evidence
Eslicarbazepine acetate (ESL) is a new antiepileptic drug whose mechanism of action is blockade of the voltage-gated sodium channel (VGSC). However, in respect to carbamazepine and oxcarbazepine, the active ESL metabolite (eslicarbazepine) affects slow inactivation of VGSC and has a similar affinity...
Bewaard in:
| Gepubliceerd in: | Drug Des Devel Ther |
|---|---|
| Hoofdauteurs: | , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Dove Medical Press
2015
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4330027/ https://ncbi.nlm.nih.gov/pubmed/25709402 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S57409 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|